← Back to Medicine & Biotech
How to read this page. The written overview is an AI-generated educational summary. Papers, references, costs and companies are verify-yourself links — we do not fabricate citations, prices or company lists.
PART 1Executive Overview
1Definition

Precision oncology is an approach that uses genomic and molecular data from a patient's tumor or circulating tumor DNA (ctDNA) in the bloodstream to tailor treatment strategies. Liquid biopsies are a component of precision oncology that involve analyzing ctDNA found in blood samples for early detection, monitoring disease progression, and assessing treatment efficacy.

Category
Therapeutics
Best use
Cancer Detection, Monitoring
Stage
NOW
2Problem It Solves

Liquid biopsies address several key challenges in oncology: early detection of cancer, monitoring disease progression, detecting resistance to treatments, and enabling personalized therapy selection based on individual genetic profiles.

3Lifecycle / Journey Stage
early commercial
PART 2Technical & Manufacturing
4How It Works

Liquid biopsies employ advanced sequencing technologies to detect and analyze small amounts of DNA from cancer cells circulating in the bloodstream. These tests can identify specific genetic mutations or other molecular markers associated with a particular type of cancer. The process involves collecting blood samples, isolating ctDNA, and using high-throughput sequencing techniques to sequence the DNA and identify relevant biomarkers.

5Materials Used
6Manufacturing / Creation Process

The manufacturing process for liquid biopsy tests involves developing and validating assays for specific biomarkers. This includes designing primers and probes for targeted sequencing, optimizing sample preparation techniques, and ensuring the accuracy and reproducibility of results through rigorous quality control measures.

7Build Process

Building a liquid biopsy test requires integrating multiple technologies such as blood collection devices, ctDNA isolation methods, next-generation sequencing platforms, bioinformatics tools for data analysis, and clinical validation studies to ensure reliability and clinical utility.

PART 3Market & Industry
9Companies Involved
Foundation MedicineGuardant Health

Curated names only — none are invented. Use the link to find more.

Find suppliers & makers ↗
10Estimated Costs

Cost drivers only — no verified dollar figures are shown. Check live sources for prices.

Search current prices ↗
11Case Studies

Illustrative — search real, dated examples rather than trusting a generated story.

Search case studies ↗
PART 4Academic References
12Scientific Papers / White Papers

Live searches — we don't list papers we can't verify.

Google Scholar ↗Semantic Scholar ↗PubMed ↗Crossref ↗
13Patents

Live patent searches — filings are never listed from memory.

Google Patents ↗Espacenet ↗
14Glossary
Liquid biopsy
A minimally invasive diagnostic test that analyzes circulating tumor DNA in the bloodstream to detect cancer, monitor disease progression, and assess treatment efficacy.
Circulating tumor DNA (ctDNA)
Small fragments of DNA released by dying cancer cells into the bloodstream. These can be detected and analyzed for genetic mutations associated with specific types of cancer.
15References

Verify against primary sources only.

Google Scholar ↗Crossref ↗Wikipedia ↗
Related Technologies

Source: curated technology intelligence stream with tracked references.